Evaluation of Prescribing Pattern of Drugs in Hemodialysis Patients

Year : 2024 | Volume : 01 | Issue : 02 | Page : 20-26
By

    Reshma Begum

Abstract

Background: Patients undergoing hemodialysis often exhibit a high level of dependency and frequently present with multiple co-morbid conditions Chronic kidney disease (CKD) poses a significant global public health challenge, with its association with numerous complications. Prescribing medications appropriately for individuals with CKD presents a substantial challenge. Objective: The study aimed to assess the prescribing patterns of drugs in hemodialysis patients. Results: Out of the total 82 selected patients, 42 (51%) were male, and 40 (49%) were female. The prescribed drugs for dialysis patients included cardiovascular drugs (73.14%), gastrointestinal drugs (90.23%), antidiabetics (52.86%), hematopoietic agents (82.92%), vitamins and minerals (68.27%), and antibiotics (63.92%). Conclusion: The study’s conclusion indicates that individuals undergoing dialysis predominantly consisted of elderly patients with concurrent co-morbid conditions. The prescribed medications for dialysis patients primarily included cardiovascular drugs, gastrointestinal drugs, antidiabetics, hematopoietic agents, vitamins and minerals, as well as antibiotics.

Keywords: Chronic Kidney Disease, ESRD, Hemodialysis, Prescription patterns, Co morbid conditions.

[This article belongs to International Journal of Antibiotics(ijab)]

How to cite this article: Reshma Begum Evaluation of Prescribing Pattern of Drugs in Hemodialysis Patients ijab 2024; 01:20-26
How to cite this URL: Reshma Begum Evaluation of Prescribing Pattern of Drugs in Hemodialysis Patients ijab 2024 {cited 2024 Feb 03};01:20-26. Available from: https://journals.stmjournals.com/ijab/article=2024/view=131733

References

Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: Global dimension and perspectives. Lancet. 2013; 382(9888):260-2.
Strehblow C, Smeikal M, Fasching P. Polypharmacy and excessive polypharmacy in octogenarians and older acutely hospitalized patients. Wien Klin Wochenschr. 2014; 126(7-8):195-200.
Burnier M, Pruijm M, Wuerzner G, Santschi V. Drug adherence in chronic kidney diseases and dialysis. Nephrol Dial Transplant.2015; 30(1):39–44.
Oliveira AP, Schmidt DB, Amatneeks TM, Santos JC, Cavallet LH, Michel RB. Quality of life in hemodialysis patients and the relationship with mortality, hospitalizations and poor treatment adherence. Jornal Brasileiro de Nefrologia. 2016 Dec; 38(4): 411-20.
Turlapati S, Konduri P, Maheshwaram LS, Loka SK, Yellu S, Bijja SF. EVALUATION OF HEALTH RELATED QUALITY OF LIFE IN HAEMODIALYSIS PATIENTS IN A TERTIARY CARE HOSPITAL. International Journal of Pharmaceutical Sciences and Research, 2015 Nov 1; 6(11):
Merkus MP, Jager KJ, Dekker FW, de Haan RJ, Boeschoten EW, Krediet RT. Physical symptoms and quality of life in patients on chronic dialysis: results of The Netherlands Cooperative Study on Adequacy of Dialysis (NECOSAD). Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association- European Renal Association, 1999 May 1; 14(5): 1163-7
Cormicheal P, Popoola J, John I, Stevens PE, Carmichael AR. Assessment of quality of life in a single centre dialysis population using the KDQOL-SFTM questionnaire. Quality Life Res. 2000; 9(2): 195-205.
Jha V, Wang AY, Wang H. The impact of CKD identification in large countries: The burden of illness. Nephrol Dial Transplant. 2012;27(Suppl 3):iii32–8.
Chaudhari ST, Sadavarte AV, Chafekar D. Clinical profile of end stage renal disease in patients undergoing hemodialysis. MVP JMS. 2017; 4(1): 8-13.
Rajapurkar M, Dabhi M. Burden of disease—prevalence and incidence of renal disease in India. Clinical nephrology. 2010 Nov 1;74(1):S9.


Regular Issue Subscription Original Research
Volume 01
Issue 02
Received January 20, 2024
Accepted January 23, 2024
Published February 3, 2024